Natural Gas ETFs Slide as Genomic Revolution Gains Momentum (ARKG, FCG)

Natural Gas ETFs Slide as Genomic Revolution Gains Momentum

Apr 14, 2026 16:07 UTC

ARKG, FCG

Immediate term

Market activity on Tuesday revealed a stark divergence between the energy and biotechnology sectors, with natural gas assets underperforming while genomic-focused ETFs climbed. The First Trust Natural Gas ETF (FCG) experienced a notable decline, reflecting broader weakness in the natural gas space. This downward trend was amplified by significant losses in specific energy components, suggesting a bearish outlook for exploration and production firms during the session. Quantifiable losses were concentrated in key holdings. FCG dropped approximately 2.9% during Tuesday afternoon trading. The decline was driven heavily by Riley Exploration Permian, which plummeted 10.4%, and W&T Offshore, which fell 6.7%. While the ARK Genomic Revolution ETF (ARKG) posted gains, the volatility in the energy sector indicates a period of instability for natural gas equities. Traders are closely monitoring these shifts as sector rotation continues to influence short-term price action across diversified ETFs.

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Natural Gas ETFs Slide as Genomic Revolution Gains Momentum

Sign up free to read the full analysis

Stay Ahead of the Markets

Wait — Don't Miss Out!